AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2023
Jan 3, 2023
29821_dirs_2023-01-03_ff3a46cc-7ddd-440c-a881-b669eeada651.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2023-01-01
Reporting Person: Butcher Arthur C (EVP& Grp Pres, MedSurg & APAC)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-01-01 | Common Stock | M | 8405.0000 | $0.0000 | Acquired | 39262.0000 | Direct |
| 2023-01-01 | Common Stock | F | 3904.0000 | $46.2700 | Disposed | 35358.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-01-01 | Performance Share Units | $ | M | 8405.0000 | Disposed | 2022-12-31 | Common Stock (8405.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2546.0000 | Indirect |
Footnotes
F1: On February 18, 2020, the reporting person was awarded a target number of performance share units under the Company's 2020 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2020 adjusted free cash flow measured against its 2020 financial plan over the one-year performance period ending December 31, 2020 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2021, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon completion of the individual service period that ended on December 31, 2022.
F2: Includes shares acquired on June 30, 2022 under the Boston Scientific Employee Stock Purchase Plan (formerly Boston Scientific Global Employee Stock Purchase Plan) based upon the most current data available.
F3: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F4: Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.